Welcome to our dedicated page for Herborium Group news (Ticker: HBRM), a resource for investors and traders seeking the latest updates and insights on Herborium Group stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Herborium Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Herborium Group's position in the market.
Herborium Group, Inc. (OTC Pink: HBRM) has entered the manufacturing phase for its new Skin Protein Bars, targeting a projected $3 billion US protein bar market by 2027. The bars will support healthy weight and sugar management and come in various flavors. The launch is expected in the 4th Quarter of 2021, accompanied by a national sampling campaign for customers and investors. The company also reported positive revenues and no dilution for the third quarter of 2021, marking its sixth consecutive profitable quarter since 2020.
Herborium Group (OTC Pink: HBRM) has expanded its presence in France, the world's second largest cosmetic market, valued at $8 billion in 2021. The company has hired a new French Market Marketing Manager to enhance its strategy. Key partnerships are being established with Wilbiz, Tresors D’Argan, and Amazon France, capitalizing on the significant growth in online skincare sales. Over 25% of the French population suffers from acne, making Herborium’s AcnEase product relevant and market-ready. Predictions indicate a 50% growth in sales for 2022.
Herborium Group, Inc. (HBRM) announced that it expects sales of its proprietary AcnEase® skin stem cell products and Skin Protein Bar to commence on Amazon France by Fall 2021. The online skincare market in France surged 123% in 2020, with body care growing 225%. Following this launch, Herborium plans to penetrate the second-largest French online retailer, cdiscount.com, which had revenues of $2.2 billion in 2020. Additionally, an updated website is set for deployment by the end of September 2021, aligning with new OTC regulations.
Herborium Group, Inc. (HBRM) reported a profitable second quarter of 2021, marking its fifth consecutive profitable quarter. The company highlighted a 66% profit margin and a 12% reduction in expenses compared to last year. Notably, there was no dilution of shares. Herborium is working on corporate governance improvements and plans to launch its proprietary Skin Protein Bar in Q4 2021, tapping into the rapidly growing protein bar market projected to reach $7.03 billion by 2027. The company is also expanding its distribution in Asia.
Herborium Group (OTC Pink: HBRM) is entering the $7.03 billion global protein bar market with the launch of its proprietary protein derma-bar in Q4 2021. This innovative product targets both skin health and weight management, appealing to protein bar consumers and the growing functional foods market. The U.S. beauty supplements market saw growth of 61% last year, positioning Herborium favorably. Target retailers include Whole Foods, Trader Joe's, Walmart, and Target, enhancing distribution potential. CEO Dr. Agnes Olszewski expressed optimism about revenue generation from this product.
Herborium Group, Inc. (HBRM) reported a strong first quarter for 2021, with sales up 19.7% and a gross profit increase of 15.1%, raising gross margin from 61% to 64%. The company successfully retired $500,000 in debt, positioning itself for future partnerships. Key developments include the launch of proprietary masks to combat viral transmission and the expansion of its Advisor Board. Dr. Ashok N. Vasvani joined the team to assist in product development. Herborium continues to focus on botanical medicinal products targeting emerging market opportunities.
Herborium Group (OTC Pink: HBRM) announced the addition of renowned endocrinologist Dr. Ashok N. Vaswani to its Advisory Board. The company is advancing plans to introduce a new all-natural product in Q3 2021 and has initiated the development of a unique digital content product for 2022. This move aligns with the growing demand for content in digital commerce, projected to reach $414.2 billion by 2025. CEO Dr. Agnes Olszewski expressed confidence in Dr. Vaswani's expertise to boost Herborium's product offerings and ESG initiatives.
Herborium Group, Inc. (HBRM) announces its acne treatment, AcnEase®, is targeting the Asia Pacific market, which includes 0.5 billion potential consumers. With a projected market growth of 6% in the skincare sector by 2022, AcnEase® aims to capture 0.5% of this demographic, estimating a market potential of $250 million.
The company has signed a distribution agreement with Phinix Global Pte. Ltd. to enhance its market presence. Sales are anticipated to start in early Q3 2021.
Herborium Group, Inc. (HBRM), a botanical therapeutics company, has introduced an innovative antimicrobial, anti-viral, water-repellent face mask, named ME-Mask, aimed at protecting against COVID-19 transmission. The mask, utilizing proprietary Japanese technology, offers a 99.98% water repellency and retains its efficacy for 30 washes. Priced at under $0.70 per use, the ME-Mask targets a growing market, with expectations of a $31.83 billion face mask market by 2027. The company aims to expand its revenue and product line while addressing skin issues like mask acne.